Susceptibility of human influenza viruses from Australasia and South East Asia to the neuraminidase inhibitors zanamivir and oseltamivir.
about
Resistance to anti-influenza drugs: adamantanes and neuraminidase inhibitorsInjectable peramivir mitigates disease and promotes survival in ferrets and mice infected with the highly virulent influenza virus, A/Vietnam/1203/04 (H5N1)Neuraminidase inhibitors for influenza B virus infection: efficacy and resistanceHigh-Efficiency Capture of Drug Resistant-Influenza Virus by Live Imaging of Sialidase ActivityDiagnosis and antiviral intervention strategies for mitigating an influenza epidemic.Drug resistance in influenza A virus: the epidemiology and management.Avian flu: isolation of drug-resistant H5N1 virus.Potential risks associated with the proposed widespread use of Tamiflu.Antiviral drug profile of human influenza A & B viruses circulating in India: 2004-2011.Zanamivir-resistant influenza viruses with a novel neuraminidase mutationGenotyping assay for the identification of 2009-2010 pandemic and seasonal H1N1 influenza virus reassortants.Assessment of pandemic and seasonal influenza A (H1N1) virus susceptibility to neuraminidase inhibitors in three enzyme activity inhibition assays.Pandemic (H1N1) 2009 and seasonal influenza A (H1N1) co-infection, New Zealand, 2009Identification of oseltamivir resistance among pandemic and seasonal influenza A (H1N1) viruses by an His275Tyr genotyping assay using the cycling probe method.Detection of resistance mutations to antivirals oseltamivir and zanamivir in avian influenza A viruses isolated from wild birdsNeuraminidase inhibitor susceptibility testing in human influenza viruses: a laboratory surveillance perspective.Mutations I117V and I117M and oseltamivir sensitivity of pandemic (H1N1) 2009 viruses.Delayed emergence of oseltamivir-resistant seasonal influenza A (H1N1) and pandemic influenza A(H1N1)pdm09 viruses in Myanmar.Rapid detection of the H275Y oseltamivir resistance mutation in influenza A/H1N1 2009 by single base pair RT-PCR and high-resolution melting.Influenza outbreaks during World Youth Day 2008 mass gathering.Drug susceptibility surveillance of influenza viruses circulating in the United States in 2011-2012: application of the WHO antiviral working group criteria.Neuraminidase inhibitor-resistant and -sensitive influenza B viruses isolated from an untreated human patient.Combinatorial effect of two framework mutations (E119V and I222L) in the neuraminidase active site of H3N2 influenza virus on resistance to oseltamivirCompetitive fitness of influenza B viruses with neuraminidase inhibitor-resistant substitutions in a coinfection model of the human airway epitheliumRare influenza A (H3N2) variants with reduced sensitivity to antiviral drugs.Characteristics of a widespread community cluster of H275Y oseltamivir-resistant A(H1N1)pdm09 influenza in Australia.Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008.Generation and Characterization of Recombinant Influenza A(H1N1) Viruses Resistant to Neuraminidase Inhibitors.Fitness costs for Influenza B viruses carrying neuraminidase inhibitor-resistant substitutions: underscoring the importance of E119A and H274Y.Influenza neuraminidase: a druggable target for natural products.A Review of the Antiviral Susceptibility of Human and Avian Influenza Viruses over the Last Decade.Influenza viruses with B/Yamagata- and B/Victoria-like neuraminidases are differentially affected by mutations that alter antiviral susceptibility.Comparison of the clinical effectiveness of oseltamivir and zanamivir against influenza virus infection in children.Zanamivir: an influenza virus neuraminidase inhibitor.Influenza virus A (H10N7) in chickens and poultry abattoir workers, Australia.Widespread oseltamivir resistance in influenza A viruses (H1N1), South Africa.PEGylated human catalase elicits potent therapeutic effects on H1N1 influenza-induced pneumonia in mice.Therapeutic efficacy of Hypericum perforatum L. extract for mice infected with an influenza A virus.Neuraminidase inhibitor susceptibility surveillance of influenza viruses circulating worldwide during the 2011 Southern Hemisphere season.Re-understanding anti-influenza strategy: attach equal importance to antiviral and anti-inflammatory therapies
P2860
Q22305941-EC35EED7-C2C1-4F8D-87D1-7110ED823E68Q24645944-30916B0F-8887-4E44-ACD4-76C7C09CAB6BQ27021579-C4C74B3A-A0F2-4026-A1F0-78E12D789316Q28552500-F1DE04F6-48F5-46C4-9CF1-9A29CFF8F22CQ30226721-B0A9108A-C02C-431F-ACDE-F26C0AC3E607Q30234600-84B07B51-EF35-4EA1-A0E3-1B819C9BA694Q30351638-6503B80E-F0C4-4F1E-BD49-4D4146BEDA06Q30360496-A14EC915-D394-43F2-8CC2-1F922FCC4017Q30367631-20657F79-5B26-4891-A0A5-15A8B32C270DQ30379353-31FFC5A9-9BB2-4CB9-93AD-880F2504CAEFQ30388744-CAD3AF2F-03F8-4118-B6F5-61704D3BDC81Q30390818-023CE4B2-58B5-4C18-B658-FA08B451B387Q30394182-77B2E6EB-6ECA-4CBB-BC91-F669F56B0516Q30396357-14A131DD-607B-4686-BDFD-ACE53C7DF1DEQ30398804-EBA0BF0D-F36D-43C9-A3A8-C392EF9AFBF6Q30408105-D558B0DE-87EB-4112-96E6-02F2156D58B8Q30411999-02C3605F-5716-475B-B95F-BF1372D34DE6Q30423174-617362D0-1312-46E1-8859-0175FFF310CFQ33952453-E28E427C-17FB-4CA8-A876-D5F0EA4C433FQ34194046-F1F651A7-6F5C-40CB-B4E8-4FA2514A8825Q34292717-E8E7AF68-B907-460A-BBE0-DC3CCD0F4677Q34648838-F0D28D5E-A2EE-475A-8F49-E8808E9E4A39Q35005209-499287A3-64B8-4E29-854A-CBF911819056Q35640944-4ECBF352-5DAC-4DFE-AD09-E6485A4430F6Q35877412-8B04DFCE-71BF-489A-92C5-8D50898A940FQ36048315-58FAC5C4-0559-44EF-A7F4-09F03549B6FDQ36870919-C6C232E1-9529-4864-A7CF-29D2D02E5FB3Q37579690-763D91EC-7292-4C70-ABD2-6165BF6BBCF1Q37713074-AC4A00E1-1E6D-4E37-932E-E8C9EB31E389Q37949284-C600398D-3006-49D7-86E6-404D1B971559Q38209673-021E3B80-39B8-42AB-8A3B-D3CC1911FA03Q39027771-35BB1B23-89D1-4C4C-9DFE-2FA76BDE95BDQ40415936-60BE8520-FDE3-41A1-9E7F-F034D63D4A70Q40419399-AF68FEB4-80C3-4BA6-A55B-F80B4FA898E6Q41991090-40E12DC3-13C8-4756-BB7C-6A412A58DBEEQ43194215-100C35F4-B2B1-48B9-9630-2B46943AF90EQ43420144-6CAAE199-CA4E-4A21-B499-E0CB4175F6D6Q45360301-EED03388-B7DF-42C6-859B-8C47387C90DFQ45947329-BDB3A29B-53A5-47D4-B919-8A5E38F43863Q57930420-BDE4403E-1948-449A-8A74-F0A857582132
P2860
Susceptibility of human influenza viruses from Australasia and South East Asia to the neuraminidase inhibitors zanamivir and oseltamivir.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Susceptibility of human influe ...... ors zanamivir and oseltamivir.
@en
Susceptibility of human influe ...... ors zanamivir and oseltamivir.
@nl
type
label
Susceptibility of human influe ...... ors zanamivir and oseltamivir.
@en
Susceptibility of human influe ...... ors zanamivir and oseltamivir.
@nl
prefLabel
Susceptibility of human influe ...... ors zanamivir and oseltamivir.
@en
Susceptibility of human influe ...... ors zanamivir and oseltamivir.
@nl
P50
P1433
P1476
Susceptibility of human influe ...... ors zanamivir and oseltamivir.
@en
P2093
Alan W Hampson
P356
10.1016/J.ANTIVIRAL.2003.11.008
P577
2004-04-01T00:00:00Z